blog navigation

blog posts

  • New drug agent knocks out multiple enzymes in cancer pathway

    University of Illinois chemistry department research scientist Yonghui Zhang, left, chemist Rong Cao, chemistry professor Eric Oldfield, and their colleagues engineered a new bisphosphonate drug that is about 200 times more effective at killing cancer cells than a bisphosphonate drug used in a recent clinical trial.

    University of Illinois chemistry department research scientist Yonghui Zhang, left, chemist Rong Cao, chemistry professor Eric Oldfield, and their colleagues engineered a new bisphosphonate drug that is about 200 times more effective at killing cancer cells than a bisphosphonate drug used in a recent clinical trial.

    Photo by L. Brian Stauffer

    Images

    • Close

      University of Illinois chemistry department research scientist Yonghui Zhang, left, chemist Rong Cao, chemistry professor Eric Oldfield, and their colleagues engineered a new bisphosphonate drug that is about 200 times more effective at killing cancer cells than a bisphosphonate drug used in a recent clinical trial.

      Photo by L. Brian Stauffer

blog posts